RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+25.65%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$918M
AUM Growth
+$918M
(+13%)
Cap. Flow
-$49.1M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
48.26%
Holding
69
New
15
Increased
16
Reduced
21
Closed
14
Top Buys
| 1 |
Gilead Sciences
GILD
|
$34.7M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$27.5M |
| 3 |
AstraZeneca
AZN
|
$18.2M |
| 4 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$17.3M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$16.6M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$39.5M |
| 2 |
HCA Healthcare
HCA
|
$23.2M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$20.9M |
| 4 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$18.8M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$18.1M |
Sector Composition
| 1 | Healthcare | 79.69% |
| 2 | Technology | 2.51% |
| 3 | Communication Services | 1.69% |
| 4 | Financials | 0.72% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $57.2M | 6.23% | 6,875,274 +1,168,368 | +20% | +$9.72M |
|
|
ARRY
2
DELISTED
Array Biopharma Inc
ARRY
| $56.1M | 6.11% | 11,858,294 +3,516,249 | +42% | +$16.6M |
|
3
Bausch Health
BHC
$2.74B
| $48.4M | 5.27% | 338,477 +5,910 | +2% | +$846K |
|
|
CMRX
4
DELISTED
Chimerix, Inc.
CMRX
| $46.6M | 5.07% | 1,157,184 +36,152 | +3% | +$1.46M |
|
|
RAD
5
DELISTED
Rite Aid Corporation
RAD
| $45.4M | 4.94% | 6,038,734 +778,024 | +15% | +$5.85M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $40.4M | 4.4% | 721,632 -62,827 | -8% | -$3.52M |
|
|
RCPT
7
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $38.3M | 4.17% | 312,736 -127,142 | -29% | -$15.6M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $38.3M | 4.17% | 342,349 -27,051 | -7% | -$3.03M |
|
9
Adverum Biotechnologies
ADVM
$64.6M
| $37.8M | 4.11% | 699,070 -390 | -0.1% | -$21.1K |
|
|
10
Gilead Sciences
GILD
$140B
| $34.7M | 3.78% | +368,615 | New | +$34.7M |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $31.6M | 3.44% | 983,966 +855,736 | +667% | +$27.5M |
|
|
TRIV
12
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $22.1M | 2.4% | 1,755,568 +4,050 | +0.2% | +$50.9K |
|
|
ZSPH
13
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $21.8M | 2.37% | 524,702 +50,570 | +11% | +$2.1M |
|
|
TVTY
14
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $21.2M | 2.31% | 1,068,489 +41,986 | +4% | +$835K |
|
15
Standard BioTools
LAB
$481M
| $20.6M | 2.24% | 610,442 +50,820 | +9% | +$1.71M |
|
|
16
AstraZeneca
AZN
$248B
| $18.2M | 1.98% | +258,305 | New | +$18.2M |
|
17
McKesson
MCK
$85.4B
| $18.2M | 1.98% | 87,523 -74,242 | -46% | -$15.4M |
|
18
Puma Biotechnology
PBYI
$254M
| $17.8M | 1.93% | 93,865 +42,840 | +84% | +$8.11M |
|
|
NSTG
19
DELISTED
NanoString Technologies, Inc.
NSTG
| $17.6M | 1.92% | 1,266,538 -187,117 | -13% | -$2.61M |
|
|
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $17.5M | 1.9% | 990,810 -12,686 | -1% | -$224K |
|
|
BLCM
21
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $17.3M | 1.88% | +860,809 | New | +$17.3M |
|
|
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
| $16.9M | 1.84% | 358,679 -139,762 | -28% | -$6.59M |
|
|
HNT
23
DELISTED
HEALTH NET INC
HNT
| $16.5M | 1.8% | 309,045 -25,890 | -8% | -$1.39M |
|
24
ProQR Therapeutics
PRQR
$237M
| $15.7M | 1.71% | 751,171 -14,061 | -2% | -$294K |
|
25
Insmed
INSM
$28.8B
| $15.7M | 1.71% | 1,012,371 -78,253 | -7% | -$1.21M |
|